Furthermore, abundant IL-10 expression is accompanied by an increase in other inflammatory mediators and its expression worsens the outcomes of various cancers, suggesting that IL-10 can serve as a key regulator of tumor immunity [22, 23]. The gene discussed is IL10; the disease is cancer.